InvestorsHub Logo

Chuckles759

07/17/20 9:43 AM

#94982 RE: Theforce123 #94978

I believe the day has not closed yet my friend.

I know that's how a stock is valued from day to day.

Bulldog88

07/17/20 10:01 AM

#95000 RE: Theforce123 #94978

Unblinding is not an event to PR. After data analysis, they will PR results likely early next week. I expect the unblinded trial yesterday or today and are beginning to analyze data now and over the weekend.

justdafactss

07/17/20 11:20 AM

#95047 RE: Theforce123 #94978

NP said unblinding Thurs or Fri. Remember? Hummm?

Yup, its Friday and they probably have the unblinding results by now.

Not looking good for the CYDY faithful at all.

The oNiOnHEAd

07/17/20 11:51 AM

#95065 RE: Theforce123 #94978

I think someone once posted something about looking at the Big Picture. Ok, maybe more than once. But if you think expecting a PR on the same day clinical study results are released, or announcing the conclusion of the trial within a few followup days is looking at the Big Picture... Furthermore, someone has stated that leronlimab has no role in Covid-19. How wrong that is. Some might be speculating that leronlimab can not help the mild to moderate cases. Again - how wrong. Based on the information I've seen, leronlimab will stop Covid-19 from advancing to severe cases. I don't care one whit if leronlimab reduces time it takes to recover from 11 days to 7, or 14 to 10. What I'll be looking for, and expecting is that the % of patients that advance to severe stage Covid-19 will be significantly reduced. That will be hidden in the numbers, but THAT is what will make Cytodyn stock fly. All the people selling their shares at the dirt bottom prices will soon be very sorry.